AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Povidone-Iodine 100,0 Mg

9 registrations across 1 African market— 6 active

Markets with Povidone-Iodine 100,0 Mg

Recent registrations

Brand / ProductMarketHolderStatusExpires
BETADINE ANTISEPTIC SOLUTION🇿🇦South AfricaiNova Pharmaceuticals (Pty) LtdactiveMar 2029
BETADINE DOUCHE🇿🇦South AfricaMundipharma (Pty) LtdsuspendedSept 2025
STERIDINE ANTISEPTIC OINTMENT🇿🇦South AfricaXERAGEN LABORATORIES (PTY) LTDsuspendedApr 2025
BETADINE VAGINAL GEL🇿🇦South AfricaMundipharma (Pty) LtdsuspendedSept 2022
SKINCEPT🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJan 1900
POVIGEL🇿🇦South AfricaMedicine Developers International (Pty) LtdactiveJan 1900
VARICIDE ANTISEPTIC SOLUTION🇿🇦South AfricaLeBasi Pharmaceuticals (Pty) LtdactiveJan 1900
SEPTISOOTH ANTISEPTIC GEL🇿🇦South AfricaPharmacorp (Pty) LtdactiveJan 1900
POVIDONE MDI GEL🇿🇦South AfricaMedicine Developers International (Pty) LtdactiveJan 1900

Povidone-Iodine 100,0 Mg in Africa — Regulatory Overview

Povidone-Iodine 100,0 Mg is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.